Orange Book Blog

American Conference Institute will be holding its Pharma/Biotech Patent Boot Camp conference in San Francisco, September 18-19.

According to ACI, the conference “has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries–as well as business executives in pharma and biotech companies–a strong working knowledge of essential IP and regulatory competencies relative to life sciences patents.”

The following talks sound particularly informative:

• Pre-Patent Considerations Relative to Product Development, Commercialization and Life Cycle Management
• Freedom to Operate: Analysis and Opinions for Pharma and Biotech Patents
• Finding Safe Harbors for Life Sciences IP: Assessing Protections and Identifying Infringing Activities Relative to Third-Party Patents
• The Nature of the Approval Process for Drugs and Biologics: What Every Life Sciences Patent Attorney Should Know
• Patent and IP Overview for Drugs and Biologics: Hatch-Waxman, Trade Dress and More
• Patent and Non-Patent Exclusivity
• Bioequivalence and the “Same Active Ingredient” vis-a-vis Patentability
• Exploring Pharmaceutical Patent Extensions: Patent Term Adjustment and Patent Term Restoration

The co-chairs of the conference are MaCharri R. Vorndran-Jones (patent counsel, Eli Lilly and Co.) and Thomas J. Kowalski (partner, Frommer Lawrence & Haug LLP).  Additional details and registration information are available at the conference website.

Orange Book Blog is a media partner of this conference.